PEP-Therapy extends Series-A financing, raising a total of €5.4 million to progress the clinical ...

Retrieved on: 2021-07-19 06:56:15

Tags for this article:

Click the tags to see associated articles and topics

PEP-Therapy extends Series-A financing, raising a total of €5.4 million to progress the clinical .... View article details on hiswai:

Excerpt

PARIS, July 19, 2021 /PRNewswire/ -- PEP-Therapy, a biotechnology company developing cell penetrating peptides as targeted therapies for the ...

Article found on: markets.businessinsider.com